Contemporary Management of HIV 2021

In this engaging meeting series available throughout the United States, expert faculty review key data informing the optimal use of contemporary HIV treatment. Full details of the many available topics are provided below.

To Host an Event
You know best what educational topic(s) would be most valuable in your local area, so let us know and we can arrange the details. We will work with you to choose the topic, date/time, and speaker. On the day, you will introduce the speaker and help lead the discussion. There will be no cost to the host or the attendees.

Please contact us at meetings@clinicaloptions.com to learn more.

Agenda

Specific meetings can focus on any of the following aspects of the management of ART:

  • Individualizing First-line ART
  • Modifying ART in Virologically Suppressed Patients
  • Emerging Paradigms in ART
  • ART Strategies for Heavily Treatment–Experienced Patients
  • Frontiers in HIV Prevention
  • Integrating New Data From CROI 2021
  • Integrating New Data From IAS 2021

The timing and agenda for each individual meeting is as follows:

  • Welcome, CME information, and baseline outcomes questions (10 mins)
  • Case 1 discussion followed by didactic slides (10-15 mins)
  • Case 2 discussion followed by didactic slides (10-15 mins)
  • Case 3 discussion followed by didactic slides (10-15 mins)
  • Question and answer session, concluding outcomes questions (15-20 mins)

Events

Date / Time
Event Details

Faculty

Program Director
Joseph J. Eron, MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Princy N. Kumar, MD

Professor of Medicine and Microbiology
Chief, 
Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Faculty
Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Faculty
Gregory Huhn, MD

Associate Professor
Department of Infectious Diseases
Rush University Medical Center
Attending Physician
Department of Infectious Diseases
Cook County Health
Chicago, Illinois

Faculty
Daniel R. Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Goal Statement
The goal of this activity is to improve learners’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives

  • Integrate best practices in the management of first-line ART and regimen modifications in virologically suppressed patients
  • Apply optimized management strategies for patients with HIV with virologic failure in the setting of an extensive treatment history and multiclass drug resistance
  • Incorporate the latest data and expert insights on emerging innovative ARV treatment or prevention paradigms into the individualized care of persons with or at risk of HIV infection, as appropriate
  • Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. UAN: Individual topic ACPE UANs available within the Event Date tab.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.